Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and leukemia group B 89901

Journal of Clinical Oncology

Volumn 24, Issue 16, 2006, Pages 2557-2562

  Ryan, David P ^a   Niedzwiecki, Donna ^a   Hollis, Donna ^a   Mediema, Brent E ^a   Wadler, Scott ^a   Tepper, Joel E ^a   Goldberg, Richard M ^a   Mayer, Robert J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ARTICLE; BONE MARROW SUPPRESSION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DEHYDRATION; DESQUAMATION; DIARRHEA; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERMAGNESEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOTENSION; INTESTINE OBSTRUCTION; LETHARGY; MALAISE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PELVIS PAIN SYNDROME; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE CARE; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RASH; RECTUM CARCINOMA; SENSORY NEUROPATHY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RECTUM TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33745005080     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.6754     Document Type: Article

References (23)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
2. Rich TA, Skibber JM, Ajani JA, et al: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32:1025-1029, 1995
3. Chari RS, Tyler DS, Anscher MS, et al: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221:778-786, 1995
4. Stryker SJ, Kiel KD, Rademaker A, et al: Preoperative "chemoradiation" for stages II and III rectal carcinoma. Arch Surg 131:514-518, 1996
5. Grann A, Feng C, Wong D, et al: Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49:987-995, 2001
6. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
7. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
8. Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004
9. Andre T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004
10. Hess S, Blackstock AW: Oxaliplatin: In vitro and in vivo evidence of its radiation sensitizing activity: Preclinical observation relevant to ongoing clinical trials. Proc Amer Assoc Cancer Res 41, 2000 (abstr A335)
11. Gunderson LL, Sargent DJ, Tepper JE, et al: Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22:1785-1796, 2004
12. Chiara S, Nobile MT, Gozza A, et al: Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer. Anticancer Res 24:355-360, 2004
13. Rosati G, Rossi A, Tucci A, et al: Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer. Ann Oncol 12:669-674, 2001
14. Bosset JF, Calais G, Daban A, et al: Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance - Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40:219-224, 2004
15. Gerard JP, Chapet O, Nemoz C, et al: Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol 21:1119-1124, 2003
16. Rodel C, Grabenbauer GG, Papadopoulos T, et al: Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098-3104, 2003
17. Chan A, Wong A, Langevin J, et al: Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 25:791-799, 1993
18. Landry JC, Koretz MJ, Wood WC, et al: Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: Phase I-II study. Radiology 188:423-426, 1993
19. Chen ET, Mohiuddin M, Brodovsky H, et al. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30:169-175, 1994
20. Weinstein GD, Rich TA, Shumate CR, et al: Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 32:197-204, 1995
21. Minsky BD, Cohen AM, Enker WE, et al: Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37:289-295, 1997
22. Nakfoor BM, Willett CG, Shellito PC, et al: The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer. Ann Surg 228:194-200, 1998
23. Aschele C, Friso M, Pucciarelli S, et al: A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion, and preoperative radiotherapy in locally advanced rectal cancer. Proc Am Soc Clin Oncol:132a, 2002 (abstr 527)